683 Capital Management’s GeneDx Holdings WGS Stock Holding History

683 Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,222	Closed	-$1.31M	–	361
2021 Q3	$1.31M	Hold	5,222	–	–	0.05%	134
2021 Q2	$2.41M	Hold	5,222	–	–	0.08%	117
2021 Q1	$2.57M	Sell	5,222 -17,505	-77%	-$9.1M	0.14%	94
2020 Q4	$8.28M	Buy	+22,727	New	+$7.92M	0.39%	53

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

683 Capital Management's WGS Position: Q4 2021 in Review

683 Capital Management sold out of GeneDx Holdings (WGS) in Q4 2021, closing a stake of 5,222 shares — an estimated $1.31M sold.

683 Capital Management first reported a position in WGS in Q4 2020 and held it in 4 quarters. The position peaked at $8.28M in Q4 2020. 112 funds tracked by Wall St. Rank hold WGS as of Q4 2021.

683 Capital Management reported no remaining GeneDx Holdings position as of Q4 2021 after selling out during the quarter.
683 Capital Management sold 5,222 GeneDx Holdings shares in Q4 2021, an estimated $1.31M.
683 Capital Management first reported a position in GeneDx Holdings in Q4 2020 and held it in 4 quarters.
683 Capital Management's GeneDx Holdings position peaked at $8.28M in Q4 2020.
112 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2021.

Based on 683 Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.